Prescription Drug News and Research

RSS

State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

Gov. Jerry Brown signed two bills Friday aimed at curbing prescription drug abuse but vetoed a third that could have helped the state's medical board identify reckless doctors whose patients died on pills they prescribed (Glover and Girion, 9/27).

1 Oct 2013

First Edition: September 30, 2013

Today's headlines include reports about the readiness of the health law's online marketplaces and other key provisions the day before their Oct. 1 launch date even as the looming government shutdown becomes more of a reality.

30 Sep 2013

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.

30 Sep 2013

Innovative packaging design aids convergence in the pharmaceutical industry

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing how it’s innovative packaging design aids convergence in the pharmaceutical industry.

30 Sep 2013

College of American Pathologists awards accreditation to Ameritox

Ameritox has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) for a second time, based on the results of recent onsite inspections of its laboratories.

27 Sep 2013

Allergan Licenses Rights To Medytox Candidates, In Up-To-$362M Deal

...

26 Sep 2013

UT Arlington team to lead $1M NSF grant project to develop smart rehabilitation system

A UT Arlington multidisciplinary team will lead a three-year, $1 million National Science Foundation grant project to develop iRehab, a smart rehabilitation system that can adapt and personalize therapy programs based on a patient's needs and constraints.

24 Sep 2013

Almirall and GKV-SV reach agreement on pricing of Sativex medicine in Germany

...

23 Sep 2013

Genetics in Medicine's October 2013 issue details solutions for integrating genomic data into EHR

Genetic tests can now tell us whether we are at increased risk of various cancers, heart or kidney disease, asthma and a number of other conditions.

20 Sep 2013

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.

18 Sep 2013

State highlights: Analysis finds no imminent patient danger before Texas abortion law; N.M. fraud investigation disrupts mental health care

In their successful push this summer for strict new regulations on abortion facilities and the doctors performing them, proponents said the legislation was needed because conditions at existing facilities made it unsafe for women seeking to terminate pregnancies. But a Texas Tribune review of state inspection records for 36 abortion clinics from the year preceding the lawmakers' vote turned up little evidence to suggest that the facilities were putting patients in imminent danger.

17 Sep 2013

First Edition: September 16, 2013

Today's headlines include reports about new polling indicating that the health law still faces an uphill climb.

16 Sep 2013

Consumer advocates, families harmed by dangerous doctors consider amending patient safety ballot measure

The California Medical Association blocked another bill aimed at improving patient safety yesterday, prompting consumer advocates and families harmed by dangerous doctors to consider amending a pending patient safety ballot measure to include those reforms the legislature fails to enact this year.

12 Sep 2013

FDA schedules meeting on 3 October to discuss QRxPharma's MOXDUO NDA for acute pain

QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.

6 Sep 2013

Endo Pharmaceuticals' complete response submission to AVEED NDA accepted by FDA

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has accepted for review the complete response submission made by Endo to the new drug application for its long-acting testosterone undecanoate injection, AVEED, intended for men diagnosed with hypogonadism.

6 Sep 2013

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Delos M. "Toby" Cosgrove arrived at the Cleveland Clinic in 1975 as an "incredibly poor" 34-year-old dreaming of a life as a cardiac surgeon. … As the years passed he became well-known for pioneering the replacement of heart valves, eventually assuming the chair of the department of cardiothoracic surgery.

From Medtronic 5 Sep 2013

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn Inc. announced today that it has acquired from Galantos Pharma GmbH, Mainz, Germany all assets related to their Alzheimer's prescription drug candidate - Memogain. Memogain has completed an extensive preclinical development program and is ready to proceed into Phase 1 clinical trials in late 2013. The terms of the acquisition were not disclosed.

5 Sep 2013

5LINX offers easy access to affordable healthcare from anywhere

5LINX enhancedcareMD offers easy access to affordable healthcare from anywhere, all day, every day for everyone in your household. This comprehensive, supplemental health care solution provides members with prompt access to registered nurses and medical doctors over the phone.

31 Aug 2013

Viewpoints: Rove says job losses growing under health law; GOP strategists say health overhaul is aiding their path to white house; Mich. Senators who opposed Medicaid expansion gave themselves lifetime medical benefits

Thousands of American higher-education administrators will spend part of Labor Day weekend trying to plumb the meaning of the ideas President Obama dropped on them last week to "reform" the American college and university system.

30 Aug 2013

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

OxyContin contains oxycodone, which is an opioid agonist. It is used for the management of moderate to severe pain when a constant opioid analgesic is needed for a prolonged period of time.

29 Aug 2013

Prescription Drug News and Research

State highlights: Calif. gov. signs bills on prescription drug abuse; Texas groups sue over parts of abortion law; Calif.'s drug Medi-Cal program probed

First Edition: September 30, 2013

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Innovative packaging design aids convergence in the pharmaceutical industry

College of American Pathologists awards accreditation to Ameritox

Allergan Licenses Rights To Medytox Candidates, In Up-To-$362M Deal

UT Arlington team to lead $1M NSF grant project to develop smart rehabilitation system

Almirall and GKV-SV reach agreement on pricing of Sativex medicine in Germany

Genetics in Medicine's October 2013 issue details solutions for integrating genomic data into EHR

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

State highlights: Analysis finds no imminent patient danger before Texas abortion law; N.M. fraud investigation disrupts mental health care

First Edition: September 16, 2013

Consumer advocates, families harmed by dangerous doctors consider amending patient safety ballot measure

FDA schedules meeting on 3 October to discuss QRxPharma's MOXDUO NDA for acute pain

Endo Pharmaceuticals' complete response submission to AVEED NDA accepted by FDA

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

5LINX offers easy access to affordable healthcare from anywhere

Viewpoints: Rove says job losses growing under health law; GOP strategists say health overhaul is aiding their path to white house; Mich. Senators who opposed Medicaid expansion gave themselves lifetime medical benefits

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News